Roche Diagnostics

Basel, Switzerland (Global) North American Headquarters: Indianapolis, IN, USA  All Switzerland companies → — Founded 1896
Clinical AI Platform Healthcare Conglomerate Point-of-Care Diagnostics
Pathology
Pathology AI
Public (Roche Holding AG)

Products

navify® Digital Pathology
Roche Diagnostics
Pathology AI
navify® Digital Pathology by Roche Diagnostics is an FDA-cleared enterprise software solution that enhances pathology workflow efficiency through laboratory integration, automation, and AI-powered image analysis for primary diagnosis. It offers flexible deployment and robust data security.

See all 1 product →

About Roche Diagnostics

Roche Diagnostics, a division of the multinational healthcare company Roche, develops and produces a comprehensive portfolio of medical tests and digital tools designed to provide crucial information for healthcare professionals. These solutions aim to facilitate accurate diagnoses, guide treatment decisions, and ultimately improve patient care and outcomes. The company is a global leader in in-vitro diagnostics and tissue-based cancer diagnostics, with a strong focus on developing products for areas such as cancer, cardiac health, infectious diseases, women’s health, and diabetes management.

Roche Diagnostics is actively involved in leveraging advanced technologies, including artificial intelligence (AI) and machine learning (ML), to enhance its offerings. This includes optimizing supply chains and sales operations through AI-driven predictive analytics and recommendation engines. The company is committed to harnessing AI and data-driven platforms to improve diagnostic accuracy, accelerate decision-making in pathology, and support targeted therapeutic strategies. Their approach involves integrating AI models into drug discovery pipelines, utilizing experimental and clinical data to train AI models that predict drug targets and optimize designs. Roche Diagnostics’ dedication to innovation extends to developing digital health solutions that provide insights to inform decisions and improve efficiencies in laboratories and clinics, offering virtual care and decision support for healthcare providers, and digital diagnostic solutions for patient self-monitoring.

Focus Areas

In-vitro diagnostics digital pathology artificial intelligence machine learning personalized healthcare cancer diagnostics cardiac health infectious diseases women's health diabetes management workflow automation data analytics clinical decision support drug discovery acceleration manufacturing optimization neuroimmunology rare diseases

Business Intelligence

TechnologyAI-driven predictive analytics, machine learning algorithms, digital pathology open environment (navify® Digital Pathology), NVIDIA AI factory (hybrid-cloud infrastructure, BioNeMo, Omniverse, Parabricks, NeMo Guardrails), computational pathology, data-driven platforms

What Physicians Need to Know

In-vitro Diagnostics (IVD)
Roche Diagnostics is a leader in IVD, offering a comprehensive portfolio of tests, instruments, and digital solutions for diagnosing various diseases including cancer, diabetes, infectious diseases (e.g., COVID-19, hepatitis, HPV), and cardiac conditions. They provide solutions for molecular diagnostics, clinical chemistry, immunoassays, tissue diagnostics, point-of-care testing, and next-generation sequencing. [21, 34, 36]
Digital Pathology & AI/Machine Learning
Roche is at the forefront of digital pathology, integrating over 20 advanced AI algorithms from multiple collaborators into its open environment. These AI tools enhance pathology insights, aid in cancer research and diagnosis, and support precision medicine by identifying subtle disease patterns in large imaging datasets. AI and machine learning are used to automate routine tasks, improve diagnostic accuracy, analyze patient data for appropriate test selection, and provide predictive analytics for future care. [1, 2, 12, 18, 25, 39]
Personalized Healthcare
Roche's Personalized Healthcare strategy aims to provide tailored treatments and diagnostic tools based on a patient's unique genetic makeup and disease characteristics. This approach leverages bioinformatics to analyze large datasets and integrate genomics, biomarkers, and monitoring data to inform clinical decisions. [19, 32, 33, 42]
Cancer Diagnostics
Roche offers an extensive portfolio of oncology diagnostic solutions across immunochemistry, molecular testing, sequencing, immunohistochemistry, in situ hybridization, and digital insights. They are committed to improving cancer care through innovative research, companion diagnostics (CDx) for targeted therapies, and solutions for breast, cervical, ovarian, liver, and lung cancers. [5, 14, 15, 16, 23, 35, 37, 44]
Cardiac Health
Roche provides novel, high-quality, and accurate solutions for cardiac health, including diagnostics for acute coronary syndrome (ACS) and heart failure. They are pioneers in cardiac biomarkers like high-sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide (NT-proBNP), offering numerous intended uses to identify cardiovascular risk, diagnose heart attacks, and manage heart failure. [13, 27, 28, 30, 31, 38, 42]
Infectious Diseases
Roche offers a broad portfolio of infectious disease diagnostic solutions, including immunochemistry, molecular, and blood safety solutions, as well as near-patient care diagnostics. Their focus areas include viral hepatitis, sexually transmitted infections (STIs), respiratory tract infections, transplant-transmitted infections, and sepsis. They also contribute to antimicrobial stewardship efforts. [7, 24, 26, 29, 38, 41, 45]
Women's Health
Roche is committed to women's health diagnostics across all stages of life, providing solutions for fertility, pregnancy, prenatal testing, menopause, bone health, and female cancers (breast, ovarian, cervical). They offer innovative tests and collaborate to expand access to screening, such as HPV self-collection for cervical cancer. [9, 16, 23, 35, 37, 38, 44]
Diabetes Management
Roche offers diagnostic solutions for diabetes management, including AI-driven approaches for real-time glucose readings and predictive features. [6, 21]
Workflow Automation & Data Analytics
Roche provides innovative automation and IT solutions to improve in vitro testing efficiency, streamline laboratory workflows, and reduce manual workload. Their solutions include physical and virtual connectivity, business analytics for critical insights, and smart algorithms for data aggregation, analysis, and transformation. [1, 4, 8, 10, 11, 34, 36]
Clinical Decision Support
Roche's digital health solutions and AI-powered tools aim to provide insights-driven clinical decision support, helping physicians make faster, more informed decisions and guiding the selection of appropriate diagnostic tests. [1, 2, 4, 6, 32, 34, 36, 45]
Drug Discovery Acceleration
Roche is leveraging AI and machine learning to revolutionize drug discovery, accelerating the identification of high-potential molecules, simulating chemical interactions, and optimizing clinical trials. They are expanding their AI infrastructure with NVIDIA GPUs to enhance R&D productivity. [3, 17, 22, 40]
Manufacturing Optimization
Roche utilizes digital twins powered by NVIDIA Omniverse to create virtual replicas of manufacturing facilities, allowing engineers to optimize processes and factory designs. [17, 39]
Neuroimmunology & Rare Diseases
Roche's R&D efforts, supported by AI, address healthcare challenges in neuroscience and immunology, including solutions for multiple sclerosis. They also focus on diagnostics for rare diseases. [18, 34, 42, 44]
Physician Tip

For physicians, Roche Diagnostics stands out due to its comprehensive and integrated diagnostic solutions that cover a vast array of disease areas. Their commitment to personalized healthcare, driven by advanced bioinformatics, AI, and machine learning, enables more tailored treatment decisions. The company's focus on workflow automation and digital pathology can lead to faster, more accurate diagnoses and improved lab efficiency, ultimately enhancing patient care. Roche's extensive portfolio of high-medical-value assays and instruments, coupled with clinical decision support tools, empowers physicians with reliable information at critical points in the patient journey. Their continuous innovation in biomarkers and diagnostic technologies, particularly in areas like oncology and cardiology, provides cutting-edge tools for early detection, risk assessment, and disease management. [1, 2, 4, 5, 6, 8, 13, 14, 15, 21, 30, 33, 36, 38, 42, 45]

Roche Diagnostics emphasizes building interoperable digital infrastructure that connects data from both Roche and non-Roche instruments across laboratory disciplines with key information systems like Electronic Health Records (EHR) and Laboratory Information Systems (LIS). Their navify® digital solutions are designed to integrate multiple software products and instrumentation within pathology labs, ensuring universal LIS connectivity and facilitating data routing. They also engage in strategic collaborations with technology companies like NVIDIA and AWS to enhance their AI and machine learning capabilities, further integrating advanced computing into their diagnostic and drug discovery processes. [6, 10, 22, 32, 39]

Products by Roche Diagnostics

1 product in the directory

navify® Digital Pathology
Roche Diagnostics
Pathology AI
navify® Digital Pathology by Roche Diagnostics is an FDA-cleared enterprise software solution that enhances pathology workflow efficiency through laboratory integration, automation, and AI-powered image analysis for primary diagnosis. It offers flexible deployment and robust data security.

What the Web Says

Roche Diagnostics generally receives positive to mixed reviews. As a company, it's often praised for its strong scientific focus, impactful work in healthcare, and good benefits, but some employees mention bureaucratic processes and challenges with work-life balance. Product reviews highlight reliability and comprehensive solutions, though some users note high costs and complexity.

Overall: Mixed

Strengths

  • Strong scientific focus and impactful work in healthcare
  • Comprehensive product portfolio and reliable diagnostic solutions
  • Good benefits and compensation for employees
  • Opportunities for professional development and learning
  • Positive company culture in many departments
  • Commitment to innovation and R&D

Limitations

  • Bureaucratic processes and slow decision-making
  • Challenges with work-life balance in some roles/departments
  • High cost of products and services for some customers
  • Complexity of some systems requiring extensive training
  • Internal communication issues reported by some employees
  • Perceived lack of recognition for individual contributions by some staff

Based on reviews from: Glassdoor, G2, Reddit, Capterra, Healthcare IT News

Last updated: 2026-10-23

Videos

News, demos, and interviews about Roche Diagnostics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Roche Diagnostics →

View all on YouTube

Press & Coverage

Citeline Insights
Roche Diagnostics Says China Drag Is Easing As It Eyes Return To Mid-to-High Single-Digit Growth
Roche's diagnostics division saw a 4% growth in the first nine months of 2026, with the decline in China sales narrowing to 9% in Q3 from 15% in the first half, indicating easing pricing pressure. The company anticipates a return to mid-to-high single-digit growth.
2026-10
BioPharma Dive
Roche affirms sales outlook amid doubts about its future
Roche reaffirmed its full-year sales outlook despite facing questions about its long-term prospects and an anticipated increase in generic competition for key products by 2030. The company reported a 7% increase in group sales in the third quarter of 2026.
2026-10
BioSpace
Roche presents new pivotal trial data across broad neuroimmunology portfolio at MSToronto2026
Roche announced new Phase III data for fenebrutinib in multiple sclerosis, showing reduced markers of chronic brain inflammation and comprehensive disease control. These findings, along with new Ocrevus and Enspryng data, were presented at MSToronto2026.
2026-10
Roche
FDA approves Roche's Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
Roche received FDA approval for Enspryng, an IL-6R inhibitor, as the first and only at-home subcutaneous treatment for thyroid eye disease (TED). This approval marks a significant advancement in treatment options for patients.
2026-10
Roche
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
Roche plans to invest up to $550 million in its Indianapolis Diagnostics site by 2030, establishing it as a major hub for manufacturing continuous glucose monitoring (CGM) systems. This expansion aims to create hundreds of jobs and enhance U.S. production capabilities.
2025-05
Roche
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
Roche announced a $50 billion investment in the United States over the next five years, focusing on new R&D sites and expanded manufacturing facilities for pharmaceuticals and diagnostics. This commitment is expected to create over 12,000 new jobs.
2025-04
PR Newswire
Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU
Roche received FDA approval for its PATHWAY HER2 (4B5) test and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now identify HER2-positive metastatic breast cancer patients eligible for ENHERTU treatment.
2025-12
News-Medical.Net
ABB Robotics collaborates with Roche to bring physical AI to laboratories
ABB Robotics and Roche Diagnostics are collaborating to develop new robotic solutions for clinical laboratories, focusing on autonomous mobile manipulators to enhance efficiency in sample and material handling. This partnership aims to accelerate lab automation and improve diagnostic processes.
2026-07

Frequently Asked Questions

Roche Diagnostics offers a comprehensive portfolio of in-vitro diagnostic tests, instruments, and digital solutions for diagnosing various diseases, including cancer, diabetes, COVID-19, hepatitis, and HPV. These solutions are designed to enhance efficiency across diverse settings like hospitals, reference laboratories, and point-of-care facilities, covering areas such as molecular diagnostics, clinical chemistry, immunoassays, and tissue diagnostics.
Roche Diagnostics integrates digital pathology with AI and machine learning to improve cancer diagnostics by enabling more precise and efficient analysis of tissue samples. Their navify® Digital Pathology solution, for instance, uses AI-based image analysis algorithms to assist pathologists in tasks like tumor detection, grading, and biomarker analysis, which supports personalized treatment strategies.
Roche Diagnostics focuses on providing innovative automation and IT solutions to optimize in-vitro testing efficiency and enhance clinical decision support. Their navify® Digital Solutions portfolio offers a secure, scalable platform for workflow automation, data integration, and advanced analytics, helping laboratories and healthcare providers streamline operations and make data-driven decisions.
Roche Diagnostics offers a wide range of diagnostic tools and solutions for various health topics, including cardiometabolic diseases, infectious diseases, women's health, and diabetes care. Their portfolio includes molecular testing solutions for infectious diseases like SARS-CoV-2 and influenza, glucose monitoring solutions for diabetes, and a comprehensive suite of women's health diagnostics covering fertility, prenatal testing, and female cancers.
Roche Diagnostics is committed to conducting business with high standards of ethical behavior and complying with all applicable laws, regulations, and industry codes. Their comprehensive compliance program includes a global Code of Conduct, regular training for employees, and an auditing and monitoring plan to ensure adherence to ethical guidelines, particularly concerning interactions and transfers of value to healthcare professionals.
Roche Diagnostics provides comprehensive support services, including installation, maintenance, training, and technical assistance for its diagnostic instruments. They actively engage in partnerships with healthcare providers, research institutions, government agencies, and other companies to develop innovative solutions, improve healthcare outcomes, and expand access to quality healthcare globally.
Roche is a global leader in in-vitro diagnostics with a steady growth profile, driven by its dual Pharmaceuticals-Diagnostics model. The diagnostics division is expected to grow in the low-to-mid single digits, supported by new technology acquisitions in digital imaging systems and continued investment in R&D, including AI for drug discovery and diagnostics for rare diseases and neuroimmunology.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]

aisencia GmbH is a healthcare AI company focused on revolutionizing diagnostic workflows in dermatopathology through artificial intelligence. They develop digital, AI-powered software solutions like Vistaneos and Cutaneos 80, designed to streamline pathology processes for faster, more precise, and accessible cancer diagnoses. The company’s technology aims to classify over 50 types of skin lesions, covering approximately […]

AI Agent, specifically referring to the platform accessible via https://vertexaisearch.cloud.google.com, is now known as the Gemini Enterprise Agent Platform. This platform is Google Cloud’s comprehensive and open solution for building, deploying, scaling, governing, and optimizing production-grade AI agents. It provides a unified environment that integrates machine learning models, such as generative AI agents and search […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.